| Molecular Formula | C24H17N3O6 |
| Molar Mass | 443.41 |
| Density | 1.37±0.1 g/cm3(Predicted) |
| Melting Point | >260 °C |
| Boling Point | 705.8±70.0 °C(Predicted) |
| Solubility | DMSO: soluble5mg/mL (warmed; clear solution) |
| Appearance | Yellow powder |
| Color | white to beige |
| pKa | 4.28±0.10(Predicted) |
| Storage Condition | Sealed in dry,Room Temperature |
| Hazard Symbols | Xn - Harmful![]() |
| Risk Codes | 22 - Harmful if swallowed |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.255 ml | 11.276 ml | 22.552 ml |
| 5 mM | 0.451 ml | 2.255 ml | 4.51 ml |
| 10 mM | 0.226 ml | 1.128 ml | 2.255 ml |
| 5 mM | 0.045 ml | 0.226 ml | 0.451 ml |
| biological activity | QNZ46 is a NR2C/NR2D selective NMDA receptor antagonist (acting on NR2D, NR2C, NR2A, NR2B, and GluR1, IC50 values are 3, 6, 229, >300, >300 μM respectively). |